Active, not recruitingPhase 3NCT02371460
Maternal Omega-3 Supplementation to Reduce Bronchopulmonary Dysplasia
Studying Bronchopulmonary dysplasia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- CHU de Quebec-Universite Laval
- Principal Investigator
- Isabelle Marc, MD, PhDCHU de Québec, Université Laval
- Intervention
- DHA-rich algal oil(dietary_supplement)
- Enrollment
- 800 enrolled
- Eligibility
- 16 years · FEMALE
- Timeline
- 2015 – 2026
Study locations (16)
- Foothills Medical Centre, Calgary, Alberta, Canada
- Royal Alexander Hospital, Edmonton, Alberta, Canada
- Royal Columbian Hospital, New Westminster, British Columbia, Canada
- Children's and Women's Health Centre of British Columbia, Vancouver, British Columbia, Canada
- Victoria General Hospital, Victoria, British Columbia, Canada
- St Boniface General Hospital, Winnipeg, Manitoba, Canada
- Health Sciences Centre, Winnipeg, Manitoba, Canada
- IWK Health Centre, Halifax, Nova Scotia, Canada
- Kingston Health Science Centre, Kingston, Ontario, Canada
- Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada
- CHU Sainte-Justine, Montreal, Quebec, Canada
- Jewish General Centre, Montreal, Quebec, Canada
- McGill University Health Center, Glen Site, Montreal Children's Hospital, Montreal, Quebec, Canada
- CHU de Québec-Université Laval, Centre Mère Enfant Soleil du CHUL, Québec, Quebec, Canada
- Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada
- +1 more locations on ClinicalTrials.gov
Collaborators
Canadian Institutes of Health Research (CIHR) · Laval University
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02371460 on ClinicalTrials.govOther trials for Bronchopulmonary dysplasia
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07109791National Surveillance and Prevention of Neonatal VAPUniversity of Alberta
- RECRUITINGNANCT06373289Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm InfantsUniversity of Alabama at Birmingham
- RECRUITINGPHASE2NCT07561125Effects of IVIG for BPD in Preterm Infant Born at 28 Weeks and BelowInternational Peace Maternity and Child Health Hospital
- RECRUITINGPHASE2NCT06915441Lipid Infusions to Optimize Nutrition TrialThe University of Texas Health Science Center, Houston
- RECRUITINGPHASE1, PHASE2NCT07101640PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary DysplasiaDuke University
- RECRUITINGNCT07273643Characterization of Extracellular Vesicles From the Cord Blood of Extremely Preterm New Borns and Their Correlation With Severe Morbidity and MortalityUniversity Hospital, Montpellier
- RECRUITINGEARLY PHASE1NCT07120971Metformin for Premature Infants With Bronchopulmonary DysplasiaMedical College of Wisconsin
- RECRUITINGPHASE1NCT06589245Inhaled Ciclesonide Study in Preterm InfantsVenkatesh Sampath